![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/202 | |
A61K 31/232 | |||
A61P 7/12 | |||
A61P 9/00 | |||
A61P 9/10 | |||
G01N 30/88 | |||
G01N 33/50 | |||
G01N 33/53 |
(11) | Number of the document | 2851069 |
(13) | Kind of document | T |
(96) | European patent application number | 13790182.3 |
Date of filing the European patent application | 2013-05-14 | |
(97) | Date of publication of the European application | 2015-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/JP2013/063419 |
Date | 2013-05-14 |
(87) | Number | WO 2013/172344 |
Date | 2013-11-21 |
(30) | Number | Date | Country code |
2012111900 | 2012-05-15 | JP |
(72) |
KIYOHARA Yutaka, JP
NINOMIYA Toshiharu, JP
YANO Takashi, JP
|
(73) |
Kyushu University, National University Corporation,
10-1, Hakozaki 6-chome Higashi-ku, Fukuoka-shi, Fukuoka 812-8581,
JP
Mochida Pharmaceutical Co., Ltd., 7 Yotsuya 1-chome Shinjuku-ku, Tokyo 160-8515, JP |
(54) | CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN |
CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN |